Canopy Growth $CGC and Constellatoin Brands $STZ re-negotiated the warrants.Per SA Transcript:As I highlighted during our previous conference call, and as previously addressed in the management information circular related to the Acreage deal. We and Constellation Brands agreed to a modification to the investor rights agreement with Constellation Brands. And the new investor rights agreement has two modifications related to the exercise price of their warrants, as well as the expiration date of their warrants, both of which are subject to fair value adjustments. The fair value adjustments, the accounting of which is detailed in Note 25 of the consolidated financial statements and recorded through the consolidated statement of operations resulted in a non-cash charge of $1.2 billion. Going forward, the revised Tranche A and B warrants will be accounted for as equity instruments and will not result in subsequent re-measurement in the P&L. In addition, the Tranche C warrants will be classified as a derivative liability for which the fair value will be nil given that they are based on the five day volume weighted average price or the VIVA. The remaining expense in gain items included in that total other expenses the majority of which are non-cash are further highlighted in our in MD&A for the three-months ended to 30, 2019....Current Revised Warrants Warrants Expiry Shares Price Expiry Shares Price Date Date Tranche Nov. 1, Nov. 1, A 2021 88.5 M C$50.40 2023 88.5 M C$50.40 warrants Tranche Nov. 1, Nov. 1, B 2021 51.2 M VWAP^ (1) 2026 38.4 M C$76.68 ^(2) warrants Tranche Nov. 1, C -- -- -- 2026 12.8 M VWAP^ (1) warrantsCGC needed to account for extending the warrant expiry and took a non-cash charge. This is a negative development and is of course bad news for shareholders.Canopy burnt through plenty of cash in the quarter, due to the C3 and This Works acquisitions totaling approximately 430 million. $CGC, Canopy Growth Corporation / H1 Rating: Neutral.Related:Tilray $TLRY is a SELL.Aurora $ACB is a hold.